QA: Bellicum Pharmaceuticals INC in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001358403_2023_Bellicum_Pharmaceuticals_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001358403, Bellicum Pharmaceuticals INC

  xvar xval
0 AssetsCurrent 23,801,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 22,000
3 remainder_Assets 0
4 LiabilitiesCurrent 3,772,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 5,088,403
9 ResearchAndDevelopmentExpense 21,777,351
10 remainder_Expenses 1,286
11 remainder_Revenues 1,258,838
12 remainder_NetIncome 6,571,739
13 remainder_ComprehensiveNetIncome 976
  yvar yval
0 Assets 23,823,000
1 Liabilities 3,772,000
2 Expenses 26,867,040
3 Revenues 1,258,838
4 StockholdersEquity 20,051,000
5 NetIncome -19,036,463
6 ComprehensiveNetIncome -19,035,975
7 BaseVar 31,146,796
8 EconomicCapitalRatiobeforeLimitedLiability 1.79
9 EconomicCapitalRatio 2.88

Edgar->Model Mapping

Feature Distribution

Change over Time